Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
SGYP > SEC Filings for SGYP > Form 8-K on 5-Aug-2013All Recent SEC Filings

Show all filings for SYNERGY PHARMACEUTICALS, INC.

Form 8-K for SYNERGY PHARMACEUTICALS, INC.


5-Aug-2013

Other Events, Financial Statements and Exhibits


Item 8.01 Other Events.

On August 5, 2013, Synergy Pharmaceuticals Inc. (the "Company") issued a press release announcing that it has completed an End-of-Phase 2 meeting with the U.S. Food and Drug Administration on its drug plecanatide for the treatment of chronic idiopathic constipation. The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information disclosed under this Item 8.01, including Exhibit 99.1 hereto, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, except as expressly set forth in such filing.



Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

99.1 Synergy Pharmaceuticals Inc. Press Release dated August 5, 2013.


  Add SGYP to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for SGYP - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.